共 50 条
- [48] Preemptive DLI without withdrawal of immunosuppression to promote complete donor T-cell chimerism results in favorable outcomes for high-risk older recipients of alemtuzumab-containing reduced-intensity unrelated donor allogeneic transplant: a prospective phase II trial BONE MARROW TRANSPLANTATION, 2014, 49 (05) : 616 - 621